News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VertiFlex Announces Submission Of Final PMA Module To The FDA, For The Superion® Interspinous Spacer System



4/1/2014 2:10:08 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of advanced minimally invasive spinal surgery technologies, announces submission of the final module of the pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) to support approval for the Superion® Interspinous Spacer System. The final module covers the clinical results from the Superion IDE trial evaluating the safety and effectiveness of the Superion Interspinous Spacer (Superion ISS) for the treatment of lumbar spinal stenosis.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES